Health funders increasingly view primary care as the preferred setting for the majority of health care. To date, efforts to increase diagnostic capacity for cancer have been based on a secondary care-centred model. This can lead to longer access times, higher costs and greater risks of error and delay.

The research carried out and supported by the CanTest Collaborative aims to transform the primary care doctor’s office into a hub of diagnostic excellence. By establishing new and ongoing collaborations to identify and evaluate novel and alternative approaches to cancer detection, particularly for ‘difficult-to-diagnose’ cancers, we aim to influence policy and practice to improve cancer diagnosis and patient outcomes.

CanTest researchers will work closely with our Patient and Public Involvement (PPI) team to evaluate specific tests for cancer detection, gain international perspectives of test provision and usage, and assess patient acceptability and safety for use in primary care.

We are currently developing our research portfolio and details can be viewed on our projects page. Examples of likely early studies include: